ACADIAN ASSET MANAGEMENT LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 73 filers reported holding OVID THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,531
+11.9%
1,701,228
-4.5%
0.03%
+12.5%
Q2 2023$5,839
+27.2%
1,780,730
-0.0%
0.02%
+20.0%
Q1 2023$4,592
+36.2%
1,780,873
-1.9%
0.02%
+17.6%
Q4 2022$3,372
-99.9%
1,814,562
-0.8%
0.02%
-5.6%
Q3 2022$3,363,000
-19.9%
1,829,352
-6.3%
0.02%
-14.3%
Q2 2022$4,196,000
-37.5%
1,951,463
-8.8%
0.02%
-25.0%
Q1 2022$6,715,000
+2.6%
2,139,290
+4.9%
0.03%
+16.7%
Q4 2021$6,543,000
+2.3%
2,040,084
+7.2%
0.02%0.0%
Q3 2021$6,394,000
-11.0%
1,903,162
+3.5%
0.02%
-11.1%
Q2 2021$7,188,000
+85.8%
1,838,246
+91.0%
0.03%
+80.0%
Q1 2021$3,869,000
+374.7%
962,476
+172.9%
0.02%
+400.0%
Q4 2020$815,000
+2529.0%
352,658
+8369.2%
0.00%
Q2 2020$31,000
-89.1%
4,164
-95.7%
0.00%
-100.0%
Q1 2020$285,000
-69.9%
95,738
-58.1%
0.00%
-50.0%
Q4 2019$947,000
+25.4%
228,360
-1.9%
0.00%
+33.3%
Q3 2019$755,000
+92.6%
232,738
+10.0%
0.00%
+50.0%
Q2 2019$392,000
+44.1%
211,490
+37.4%
0.00%
+100.0%
Q1 2019$272,000
+300.0%
153,898
+445.6%
0.00%
Q4 2018$68,000
-57.5%
28,2080.0%0.00%
-100.0%
Q3 2018$160,000
+3.9%
28,208
+43.0%
0.00%0.0%
Q2 2018$154,000
+196.2%
19,729
+165.4%
0.00%
Q1 2018$52,0007,4350.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders